Global Immuno Oncology Drugs Market Fueled by Precision Medicine and Targeted Therapies
Advancements in monoclonal antibody technologies are strengthening the development of immuno-oncology treatments. Continuous improvements in antibody engineering are supporting innovative approaches to cancer management. Market Overview The Immuno-Oncology Drugs Market size was valued at US$ 77.80 billion in 2024 and is expected to reach US$ 237.73 billion by 2031. The market is...
0 Comments 0 Shares 34 Views 0 Reviews
MakeMyFriends https://makemyfriends.com